Pulmonary Embolism Support Group
By far the most common form of pulmonary embolism is a thromboembolism, which occurs when a blood clot, generally a venous thrombus, becomes dislodged from its site of formation and embolizes to the arterial blood supply of one of the lungs. Symptoms may include difficulty breathing, pain during breathing, and more rarely circulatory instability and death.
I have been on Pradaxa for 3 months now instead of coumadin. I could not get regulated on Coumadin after 6 months of therapy.
The drawback to Pradaxa is the lack of a reversal agent when needed like the Vitamin K shot for Coumadin.
However, Baylor University is working on a protocol for use with the newer anticoagulants and has had some success. I found the article on theheart.org but you must have a membership to access (which is free).
Article is entitled: Role Reversal: Hematologists Advise on Bleeding With Newer Anticoagulants
I printed it and keep a copy in my purse in case I have to go to the ER so they can see the effective protocol.
The drawback to Pradaxa is the lack of a reversal agent when needed like the Vitamin K shot for Coumadin.
However, Baylor University is working on a protocol for use with the newer anticoagulants and has had some success. I found the article on theheart.org but you must have a membership to access (which is free).
Article is entitled: Role Reversal: Hematologists Advise on Bleeding With Newer Anticoagulants
I printed it and keep a copy in my purse in case I have to go to the ER so they can see the effective protocol.
-
Look at what my best friend did with my picture!
-
We all have 24 hours in a day. How we spend these hours is important. Watching a little bit of a video about how sitting affects us made me aware of how much sitting and laying down I do. Gonna have to work on that.Your turn. Tell me another truth.
http://www.stoptheclot.org/News/article309.htm
No mention there of the problem of non-reversal which led the people in the other forum to hail that as 'great news'.
Stop the clot was 'just' reporting what the NEJM reported-----
************************************
""CONCLUSIONS
A fixed-dose regimen of rivaroxaban alone was noninferior to standard therapy for the initial and long-term treatment of pulmonary embolism and had a potentially improved benefitrisk profile."
(Funded by Bayer HealthCare and Janssen Pharmaceuticals; EINSTEIN-PE ClinicalTrials.gov number, NCT00439777.)
Supported by Bayer HealthCare and Janssen Pharmaceuticals."
http://www.nejm.org/doi/full/10.1056/NEJMoa1113572?query=featured_home
***********************************
I would hope that stoptheclot could add their addendum to present what seems to be the greatest pitfall for using the 'new and great' anti-coags.
I wasn't trying to denigrate stoptheclot-----but it is one of the sites that people get referred to a lot (and mostly for good reasons).
It's just, with the Internet, and with people not wanting to, or incapable of investigating further, it's taken at face value and as the truth; "It's written on stoptheclot, isn't it?"